Five healthy human volunteers were anaesthetized on two separate occasions, 1 week apart, using a standard diazepam-ketamine induction followed by an infusion of ketamine for 1 h. Ten minutes after stopping the infusion, either 4-aminopyridine 0.3 mgkg" 1 in saline or the same volume of saline alone was administered i.v. It was concluded that 4-aminopyridine enhanced dramatically the rate of recovery of the subjects to full consciousness and normal motor co-ordination when compared with the saline controls.
The compound 4-aminopyridine (4-AP) is of interest to anaesthetists because it is a potent antagonist of the neuromuscular blocking actions of non-depolarizing myoneural blocking drugs (Lemeignan and Lechat, 1967; Paskov, Stojanov and Micov, 1973; Bowman, Harvey and Marshall, 1977; Harvey and Marshall, 1977) . In fact, it has been used clinically in Bulgaria as an antagonist to tubocurarine for several years (Paskov, Stojanov and Micov, 1973; Stojanov et al., 1976) .
In contrast to neostigmine, it is free from anticholinesterase activity and its mechanism of action appears to be pre-junctional (Lundh, Leander and Thesleff, 1977) . It enhances the release of transmitter from the motor nerve terminals (Lundh and ThesleflF, 1977; Molgo, Lemeignan and Lechat, 1977; Vizi, van Dijk and Foldes, 1977) . However, this prejunctional action appears to be a general one affecting other nerve terminals also. For instance, in the periphery, 4-AP has been shown to potentiate the effects of adrenergjc stimulation in the rabbit vas deferens (Johns et al., 1976) and its action here was considered to be presynaptic, resulting in an increased release of the sympathetic transmitter in response to nerve stimulation.
There is an increasing body of experimental evidence concerning the c.n.s. effects of 4-AP, suggesting that it crosses the blood-brain barrier freely. The central actions are thought to be mediated by a presynaptic mechanism similar to that seen in the periphery, and are not necessarily restricted to effects upon any particular type of synapse or transmitter. Thus, 4-AP has been shown to facilitate transmission in excitatory and inhibitory pathways in the spinal cord of the cat (Lemeignan, 1972 (Lemeignan, , 1973 Jankowska et al., 1977) and the sixth ganglion of the cockroach (Hue et al., 1976) . Furthermore, Nicholson and colleagues (1976) have shown that 4-AP can alter extracellular calcium and potassium concentrations in the cat cerebellum and may thereby alter the excitability of the cerebellar neurones. 4-AP has also been found to alter the turnover of monoamines in the central nervous system of rats (Anden and Leander, 1979) . Finally, a central effect of 4-AP which has a direct relevance to its use in anaesthetic practice has been noted in the cat, namely, stimulation of respiratory drive as judged by phrenic nerve activity (See, Folgering and Schlafke, 1978) .
Because it was observed, in experiments designed to investigate the antagonistic effect of 4-AP on tubocurarine-induced neuromuscular block in monkeys anaesthetized with high doses of ketamine, that 4-AP had a definite analeptic effect, even during an infusion of ketamine (S. Agoston, unpublished observation), we decided to look for interactions between 4-AP and ketamine. Healthy human volunteers were given a ketamine-diazepam anaesthetic and the effects of 4-AP upon the subsequent rate of recovery from this anaesthetic were monitored.
METHODS
Five healthy anaesthetists were subjected on two occasions, at least 1 week apart, to a ketamine-diazepam anaesthetic lasting 1 h. Following an injection of atropine 0.5 mg i.v., anaesthesia was induced in each subject with a bolus of diazepam 0.2 mg kg" 1 i.v. and ketamine 2.0 mg kg" 1 i.v. An i.v. infusion of saline containing ketamine 1 mg ml" 1 was started. During the subsequent 60 min ketamine 1 mg kg" 1 was infused so that each volunteer received in total ketamine 3 mg kg"
1 during 1 h. Ten minutes after stopping the infusion of ketamine either 4-AP 0.3 mg kg" 1 or the same volume of saline was administered i.v. Instead of measuring the "sleep time" we decided to challenge each volunteer with a battery of tests continuously after the injection of the 4-AP or the saline alone. These tests were chosen in order to obtain information about the graded return to normality of such higher cerebral functions as logical thought, recall, short-and long-term memory and general physical co-ordination. These tests are summarized in table I and consist of repeated challenging with simple mental arithmetic of increasing difficulty as the level of consciousness increased, asking the subject to read a simple sentence from a book and to recall this 15 s later, remembering dates such as his wife's birthday, the use of a calculator to perform simple arithmetic and finally the return to a fully ambulant state with no motor or sensory deficits. Diazepam was included in this regime in order to minimize the cardiovascular side-effects of the ketamine and allow amnesia of any undesirable hallucinatory experiences during the period of "dissociative anaesthesia" produced by the ketamine. Furthermore, the anaesthetic sequence used was similar to that utilized in clinical practice and it is hoped to extend this study to include patients receiving a comparable diazepam-ketamine anaesthetic.
RESULTS
The rate of recovery from the ketamine-diazepam anaesthesia was improved greatly on those occasions when the subjects received 4-AP, as judged by the time needed to perform the various tests (table I) . Statistical analysis of the results (paired Student's t test) showed a significant difference in the results obtained with and without 4-AP treatment in every test used. Subjective experiences of the recovery period were the same for all volunteers. All the subjects wakened suddenly, all senses returning simultaneously, when they received 4-AP, whereas when saline was administered the subjects drifted slowly into a state of consciousness, in some cases hearing the voices of the investigators before they became aware of them visually.
The only side-effects of 4-AP noted were a tingling sensation around the lips and in one case a "vibrating feeling" along the length of the arm where the injection site was located. No ketamine-induced hallucinations were experienced with or without 4-AP.
DISCUSSION
The results show clearly that 4-AP increased the rate of recovery of the subjects from the diazepamketamine anaesthesia as judged by the simple tests used compared with the recovery rate when saline was injected. The dose of 4-AP used (0.3 mg kg" 1 ), was relatively small and was roughly the same as that which has been used to antagonize safely the effects of tubocurarine and pancuronium in man (Stojanov et al., 1976; Miller et al., 1979) . These results maj find a clinical use in the possible administration o: 4-AP as a means of decreasing the sometimes prolonged recovery time of patients after a ketamine anaesthetic. This would alleviate not only the task of the recovery room nursing staff and be of benefit to the patient by returning him to a safe level of consciousness more quickly, but could perhaps be of especial use in conditions where a rapid recovery from ketamine anaesthesia is essential, as in a major disaster.
Several anaesthetic agents have been shown to alter the turnover of acetycholine in the brain of animals and the release of this putative central transmitter may be influenced by 4-AP. For instance, it is known that barbiturates inhibit the release ol acetylcholine and cause its accumulation in the brair (Giarman and Pepeu, 1962; Mitchell, 1963; Celesii and Jasper, 1966; Crossland and Slater, 1968) and Rao and co-workers (1977) have demonstrated an antagonism between 4-AP and the anaesthetic effects of pentobarbitone sodium and methohexitone in the rat. Furthermore, the turnover of acetylcholine is decreased in different brain areas of the rat after halothane, enfluranc or ketamine anaesthesia, each agent causing a definite pattern of changes related to the different cortical and subcortical sites of action of these agents as determined from electrophysiological studies (Ngai, Cheney and Finck, 1978) . Physostdgminc, the centrally-acting anticholinesterase, has been used successfully in the past to antagonize the effects of droperidol, benzodiazepines and other centrally-acting drugs used in clinical anaesthesia which are thought to act in part by interfering with central cholinergic pathways (Bidwai, Cornelius and Stanley, 1976; Hill, Stanley and Sentker, 1977) . However, the indirect vagotonic action of physostigmine represents a serious disadvantage to its use, necessitating the additional administration of atropine, which itself may antagonize its c.n.s. effects (Rumack, 1973) . This problem does not exist with the administration of 4-AP because of its lack of anticholinesterase activity. Indeed, Miller and colleagues (1979) have emphasized the fact that it is not necessary to give atropine when 4-AP is given in human subjects. Folgering and his co-workers have actually found evidence for antagonism of the central effects of 4-AP by atropine in the cat (See, Folgering and SchlSfke, 1978; Folgering, Rutten and Agoston, 1979) .
